News
PRE
5.94
+15.56%
0.80
Prenetics Global Announces 2024 Annual General Meeting
TipRanks · 12h ago
Weekly Report: what happened at PRE last week (1202-1206)?
Weekly Report · 4d ago
IM8 Partners with University of Oxford for Groundbreaking Space Experiment on Aging Aboard the ISS
Barchart · 12/05 17:52
Analysts Offer Insights on Healthcare Companies: Keros Therapeutics (KROS), Incyte (INCY) and Prenetics Group (PRE)
TipRanks · 12/05 16:02
Prenetics’ IM8, University of Oxford begin space experiment
TipRanks · 12/05 13:45
Prenetics' IM8 And University Of Oxford Launch Space Experiment On ISS To Study Accelerated Aging And Longevity
Benzinga · 12/05 13:34
Prenetics Global Price Target Maintained With a $9.00/Share by Cantor Fitzgerald
Dow Jones · 12/04 16:11
Cantor Fitzgerald Reiterates Overweight on Prenetics Global, Maintains $9 Price Target
Benzinga · 12/04 16:04
Prenetics Announces Participation in December Investor Conferences
Barchart · 12/04 15:05
Weekly Report: what happened at PRE last week (1125-1129)?
Weekly Report · 12/02 11:29
Prenetics Global Limited Reports 59.4% Revenue Growth and Launches Premium Supplement Brand IM8Health.com
Barchart · 11/27 17:52
Prenetics Global Q3 Loss Narrows On Surge In Revenue
NASDAQ · 11/27 14:40
Prenetics Reports Strong Growth with New Launches
TipRanks · 11/27 13:57
Prenetics Global: Q3 Earnings Insights
Benzinga · 11/27 13:40
Prenetics Global Q3 EPS $(0.84) Beats $(0.86) Estimate, Sales $7.78M Up From $5.94M YoY
Benzinga · 11/27 13:35
Prenetics reiterates FY24 revenue target exceeding $33M
TipRanks · 11/27 13:35
PRENETICS GLOBAL LTD: REITERATES REVENUE TARGET TO EXCEED $33 MILLION FOR FY 2024
Reuters · 11/27 13:30
PRENETICS GLOBAL LTD: QTRLY LOSS PER SHARE $0.84
Reuters · 11/27 13:30
PRENETICS GLOBAL Q3 GROSS MARGIN 50.8%
Reuters · 11/27 13:30
Weekly Report: what happened at PRE last week (1118-1122)?
Weekly Report · 11/25 11:21
More
Webull provides a variety of real-time PRE stock news. You can receive the latest news about Prenetics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About PRE
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients.